Acnatac

Acnatac combines Clindamycin and Tretinoin for topical acne treatment. This medication targets acne-causing bacteria and promotes skin cell turnover. Ideal for managing moderate to severe acne.

Acnatac is primarily used for the treatment of acne vulgaris. It combines Clindamycin, an antibiotic, with Tretinoin, a retinoid, to address acne-causing bacteria and promote skin cell renewal. This dual-action approach helps reduce inflammation and prevent future breakouts. Acnatac is often recommended for individuals who have not responded to other acne treatments.

When applied topically, Acnatac may cause initial skin irritation, redness, or dryness. These effects typically subside as the skin adjusts to the medication. Some users may experience peeling or mild discomfort. It is important to follow the prescribed application guidelines to minimize these effects.

Acnatac should be used as directed by a healthcare professional. Avoid contact with eyes, lips, and mucous membranes. It is advisable to use sunscreen as Tretinoin can increase skin sensitivity to sunlight. Individuals with known allergies to Clindamycin or Tretinoin should avoid using this medication.

Acnatac may interact with other topical medications, particularly those containing sulfur, resorcinol, or salicylic acid. It is important to inform your healthcare provider about all medications you are currently using. Additionally, avoid using harsh soaps or exfoliants while using Acnatac to prevent excessive skin irritation.